Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA
Go back to Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA| Pfizer Inc. (NYSE: PFE) | Delayed: 27.72 +0.07 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.65 | 52 Week High | $37.39 | |||
| Open | $27.80 | 52 Week Low | $28.25 | |||
| Day High | $27.85 | P/E | 16.80 | |||
| Day Low | $27.42 | EPS | $1.65 | |||
| Volume | 25,551,822 | |||||
